comparemela.com

Page 5 - China Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

China Pharma (NYSE:CPHI) Receives New Coverage from Analysts at StockNews com

China Pharma (NYSE:CPHI) Receives New Coverage from Analysts at StockNews com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

China Pharma (NYSE:CPHI) Earns Hold Rating from Analysts at StockNews com

StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a report issued on Saturday. The brokerage issued a hold rating on the stock. China Pharma Stock Performance CPHI opened at $0.12 on Friday. China Pharma has a one year low of $0.08 and a one year high of $1.21. The company […]

China Pharma (NYSE:CPHI) Coverage Initiated by Analysts at StockNews com

StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a report published on Saturday. The firm issued a hold rating on the stock. China Pharma Stock Performance Shares of NYSE:CPHI opened at $0.12 on Friday. The firm’s fifty day moving average is $0.11 and its 200-day moving average is $0.19. The […]

China Pharma (NYSE:CPHI) Research Coverage Started at StockNews com

China Pharma (NYSE:CPHI) Research Coverage Started at StockNews com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

StockNews com Initiates Coverage on China Pharma (NYSE:CPHI)

StockNews.com started coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a research note released on Thursday morning. The brokerage issued a hold rating on the stock. China Pharma Price Performance Shares of CPHI opened at $0.11 on Thursday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.29 and […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.